Last reviewed · How we verify
NCT04524260
The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients
NA trial testing perioperative painting art therapy (LOM® solution centered art therapy) in Lower Gastrointestinal Neoplasms Benign in 80 participants. Status unknown.
31 August 2022
Quick facts
| Lead sponsor | University of Zurich |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 31 August 2020 |
| Primary completion | 31 August 2022 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- perioperative painting art therapy (LOM® solution centered art therapy)
- perioperative painting art therapy (LOM® solution centered art therapy) - control
Conditions studied
- Lower Gastrointestinal Neoplasms Benign — all drugs for Lower Gastrointestinal Neoplasms Benign →
- Pancreas Cancer — all drugs for Pancreas Cancer →
- Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →
- Depression, Anxiety — all drugs for Depression, Anxiety →
Sponsor
University of Zurich
Who can join
18 and older, any sex, with Lower Gastrointestinal Neoplasms Benign or Pancreas Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators want to study whether the use of painting art therapy has an influence on the quality of life, the complication rate and the general outcome of major abdominal surgery. The painting art therapy is carried out according to the protocol of (LOM® Solution Centered Art Therapy) by trained painting art therapists.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04524260
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Zurich trials
Trials by the same sponsor.
- NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
- NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
- NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
- NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
- NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04524260 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Zurich
- Last refreshed: 9 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04524260.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing